Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
177lu-dota-eb-tate (1 trial)
amino acids (Freamine) (1 trial)
ferric derisomaltose (Monoferric) (1 trial)
Kidney Diseases (Phase 1)
Renal Insufficiency, Chronic (Phase 1)
Trials (2 total)
Trial APIs (3 total)